|
|
Biography |
|
|
JACQUES-FRANCOIS MARTIN
Chairman and CEO of PARTEUROP
J.F. Martin has spent a lifetime in the pharmaceutical, biological and life sciences industries.
In 1976, Martin joined the Institut Mérieux as Vice President of Sales and Marketing, where he largely contributed to its international expansion. He was named the company’s CEO in 1988, and successfully negotiated with the Government of Canada the acquisition of Connaught Laboratories.
In 1991, Martin set up Parteurop S.A.S., a biotech consulting company based in Lyon, France.
From Sept.1996 to Sept.1999, he was a member of the Board of INSERM (the French National Institute of Health).
From 1994 to 1997, Martin served as the Chairman of the Biologicals Committee of the International Federation of Pharmaceutical Manufacturers Associations. As such, he was a member of the Scientific Advisory Group of Experts of WHO (SAGE).
From Nov.1997 to June 2003 he was a member of the Board of the International AIDS Vaccine Initiative (IAVI).
From 2000 to Jan.2005, Martin was the 1st President and CEO of The Vaccine Fund. He lead the Fund’s efforts to provide lifesaving vaccines and other immunization program support to low-income countries. In this capacity, he was also a member of the Board of GAVI (Global Alliance for Vaccines and Immunization).
He is member of the Board of several life sciences companies.
Martin holds an MBA from HEC-Paris France,is a member of the French Academy of Technologies and an officer in the French Order of Merit.
|
|
|
|
|
|
|
Abstract |
|
|
|
|
|
|
|
|
|
|
|